Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Myovant Sciences Ltd. | 38,341,357 | reported | 02 Apr 2018 | tx 1+1,110,015 |
| Urovant Sciences Ltd. | 22,777,338 | reported | 03 Jun 2019 | tx 7+32,231 |
| APi Group Corp | 4,890,595 | reported | 28 Feb 2024 | tx 9+8,200,878−10,765,039 |
| Wayfair Inc. | 538,711 | reported | 20 Nov 2014 | tx 2+35,200 |
| Inhibrx, Inc. | 0 | reported | 30 May 2024 | tx 7+131,465−8,189,591 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 May 2024 | OTHER | Inhibrx, Inc. | 6,305,866 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 333,333 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 511,627 | 30.00 USD | |
| 30 May 2024 | OTHER | Inhibrx, Inc. | 1,038,765 | 30.00 USD | deriv |
| 28 Feb 2024 | CONVERSION | APi Group Corp | 8,036,862 | 24.60 USD | |
| 28 Feb 2024 | CONVERSION | APi Group Corp | 164,016 | 24.60 USD | |
| 28 Feb 2024 | OTHER | APi Group Corp | 3,983,739 | 36.90 USD | |
| 28 Feb 2024 | OTHER | APi Group Corp | 81,300 | 36.90 USD | |
| 28 Feb 2024 | CONVERSION | APi Group Corp | 196,000 | 0.00 USD | deriv |
| 28 Feb 2024 | CONVERSION | APi Group Corp | 4,000 | 0.00 USD | deriv |
| 02 Jan 2024 | SALE | APi Group Corp | 3,983 | 31.30 USD | |
| 02 Jan 2024 | SALE | APi Group Corp | 6,300,817 | 31.30 USD | |
| 02 Jan 2024 | SALE | APi Group Corp | 195,200 | 31.30 USD | |
| 25 Aug 2020 | PURCHASE | Inhibrx, Inc. | 70,479 | 19.39 USD | |
| 24 Aug 2020 | PURCHASE | Inhibrx, Inc. | 46,161 | 19.43 USD | first after silence |
| 25 Aug 2020 | PURCHASE | Inhibrx, Inc. | 14,825 | 19.23 USD | |
| 30 May 2019 | PURCHASE | Urovant Sciences Ltd. | 6,951 | 7.97 USD | |
| 30 May 2019 | PURCHASE | Urovant Sciences Ltd. | 300 | 8.91 USD | |
| 31 May 2019 | PURCHASE | Urovant Sciences Ltd. | 5,071 | 7.70 USD | |
| 03 Jun 2019 | PURCHASE | Urovant Sciences Ltd. | 5,424 | 7.71 USD | |
| 24 May 2019 | PURCHASE | Urovant Sciences Ltd. | 3,796 | 7.70 USD | first after silence |
| 29 May 2019 | PURCHASE | Urovant Sciences Ltd. | 6,882 | 7.55 USD | |
| 28 May 2019 | PURCHASE | Urovant Sciences Ltd. | 3,807 | 7.68 USD | |
| 02 Apr 2018 | PURCHASE | Myovant Sciences Ltd. | 1,110,015 | 20.27 USD | first after silence |
| 20 Nov 2014 | PURCHASE | Wayfair Inc. | 17,600 | 22.73 USD |
3 purchases reported after at least 12 months of silence — most recent on 24 Aug 2020.